Injective's token price climbed to $4.25 on Friday, triggering a technical warning as its relative strength index hit 73.21 — a level that often signals an asset is overbought. Behind the move, whale positioning points to a possible run toward $5.50 before any pullback, while a large majority of retail traders are betting the rally has room to run.
RSI at 73.21: Overbought signal
The Relative Strength Index, a momentum oscillator that measures the speed and change of price movements, crossed above 70 — the common threshold for overbought conditions. At 73.21, the reading suggests buying pressure has been unusually intense. Traders typically watch such levels for signs of an impending correction, though overbought readings can persist during strong trends.
Whale positioning and breakout dynamics
Data on large holder activity shows whales accumulating or positioning for further upside, with breakout dynamics supporting a target near $5.50. That level would represent roughly a 29% gain from current prices. The same data, however, implies that a correction could follow if the token fails to hold recent gains — a pattern often seen after sharp rallies.
Retail traders lean long at 67%
Among retail traders, 67% currently hold long positions on Injective. That heavy tilt toward one side of the trade can create conditions for explosive price movement — either fueling a continued rally if buying pressure builds, or amplifying a sell-off if the market turns. The imbalance means relatively few traders are positioned for a drop, leaving the market vulnerable to sudden reversals.
What happens next depends on whether Injective can break through resistance near its recent high and sustain momentum toward $5.50. If whales start taking profits or the RSI triggers a technical sell-off, the token could retreat just as quickly as it rose.
